A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.
The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called Fosmanogepix) for the potential treatment of candidemia and/or invasive candidiasis, a life-th...
Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy
Double blind, placebo controlled, multicenter randomized trial in pregnant women in the U.S. (N=300) to test the central hypothesis that IV iron in pregnant women with IDA (Hb\<11 g/dL and ferritin\<3...
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
Primary Objectives: To evaluate the safety (compared to iron sucrose) and efficacy of ferumoxytol in pediatric CKD subjects with iron deficiency anemia (IDA) or who are at risk of development of IDA ...
Iron Deficiency Anemia (IDA) and the Brain
This is a trial with an observational and an interventional arm, in patients with moderate to severe anemia and control subjects. The main purposes of this study is to phenotype the scope of neurocogn...
Nasal Antisepsis for C. Auris Prevention
This is a randomized, controlled, open-label trial of effect of 10% povidone iodine intranasal antisepsis on the detection of Candida auris....
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma
The primary objective is to determine the safety and efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indeterminate lesions (IL) or small choroidal melano...
A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
This is a Phase 3, randomized, open-label, multicenter, study in male and female pediatric subjects (2 years to \<18 years of age) with IDA, or felt by their clinician to be at risk of developing IDA....
Top Cities for Iron Deficiency Anemia Clinical Trials
Iron Deficiency Anemia clinical trials are recruiting across 39 cities. Here are the cities with the most active studies:
About Iron Deficiency Anemia
Iron deficiency anemia is the most common type of anemia worldwide, occurring when the body lacks sufficient iron to produce adequate hemoglobin. It causes fatigue, weakness, and pale skin. Treatment includes iron supplementation and addressing the underlying cause of iron loss.
Clinical trials are advancing new treatments for iron deficiency anemia. Currently, 7 studies are recruiting a combined 1,294 participants across the United States. Research is being conducted by 6 organizations including Basilea Pharmaceutica, Women and Infants Hospital of Rhode Island, AMAG Pharmaceuticals, Inc. and 3 others.
2026 Iron Deficiency Anemia Research Landscape
As of March 2026, the iron deficiency anemia clinical trial landscape includes 7 actively recruiting studies across 39 cities in the United States. These studies are collectively seeking 1,294 participants, with an average enrollment target of 185 per study.
Research is being led by 6 different organizations, including Basilea Pharmaceutica, Women and Infants Hospital of Rhode Island, AMAG Pharmaceuticals, Inc., Children's Hospital Los Angeles, Mary K Hayden, and 1 others.
Geographically, iron deficiency anemia trials are most concentrated in Miami, Florida (4 trials); Los Angeles, California (4 trials); Birmingham, Alabama (3 trials); Chicago, Illinois (3 trials); Sacramento, California (2 trials) and 7 other cities.
Featured Iron Deficiency Anemia Studies
Highlighted recruiting studies for iron deficiency anemia, selected by enrollment size and research scope.
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.
The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called Fosmanogepix) for the potential treatment of candidemia and/or invasive candidiasis, a life-threatening fungal infection caused by several species of yeast called Candida. The study is seeking patients who have a diagnosis of candidemia and/or invasive candidiasis. Two-thirds of all patients...
Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy
Double blind, placebo controlled, multicenter randomized trial in pregnant women in the U.S. (N=300) to test the central hypothesis that IV iron in pregnant women with IDA (Hb\<11 g/dL and ferritin\<30 ng/mL) at 13 - 30 weeks will be effective, safe and cost-effective in reducing severe maternal morbidity-as measured by maternal anemia at delivery-and will also improve offspring neurodevelopment.
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
Primary Objectives: To evaluate the safety (compared to iron sucrose) and efficacy of ferumoxytol in pediatric CKD subjects with iron deficiency anemia (IDA) or who are at risk of development of IDA Secondary Objective: To determine the single-dose pharmacokinetics (PK) and pharmacodynamics (PD) profile of ferumoxytol in pediatric subjects.
Frequently Asked Questions About Iron Deficiency Anemia Clinical Trials
Are there iron deficiency anemia clinical trials near me?
Yes, there are 7 iron deficiency anemia clinical trials currently recruiting across 39+ cities in the United States, including Miami, Florida; Los Angeles, California; Birmingham, Alabama. Browse the studies above to find one at a location convenient for you.
How do I join a iron deficiency anemia clinical trial?
To join a iron deficiency anemia clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are iron deficiency anemia clinical trials free?
Yes, participation in iron deficiency anemia clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of iron deficiency anemia treatments are being studied?
Current iron deficiency anemia clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 6 research organizations.
Is it safe to participate in iron deficiency anemia clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 1, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 1, 2026 · Data from ClinicalTrials.gov